AAAAAA

   
Results: 1-9 |
Results: 9

Authors: Khan, KNM Stanfield, KM Dannenberg, A Seshan, SV Baergen, RN Baron, DA Soslow, RA
Citation: Knm. Khan et al., Cyclooxygenase-2 expression in the developing human kidney, PEDIATR D P, 4(5), 2001, pp. 461-466

Authors: Baergen, RN Malicki, D Behling, C Benirschke, K
Citation: Rn. Baergen et al., Morbidity, mortality, and placental pathology in excessively long umbilical cords: Retrospective study, PEDIATR D P, 4(2), 2001, pp. 144-153

Authors: Baergen, RN Warren, CD Isacson, C Ellenson, LH
Citation: Rn. Baergen et al., Early uterine serous carcinoma: Clonal origin of extrauterine disease, INT J GYN P, 20(3), 2001, pp. 214-219

Authors: Rush, DS Tan, JY Baergen, RN Soslow, RA
Citation: Ds. Rush et al., h-caldesmon, a novel smooth muscle-specific antibody, distinguishes between cellular leiomyoma and endometrial stromal sarcoma, AM J SURG P, 25(2), 2001, pp. 253-258

Authors: Soslow, RA Shen, PUF Chung, MH Isacson, C Baergen, RN
Citation: Ra. Soslow et al., Cyclin D1 expression in high-grade endometrial carcinomas - Association with histologic subtype, INT J GYN P, 19(4), 2000, pp. 329-334

Authors: Soslow, RA Slomovitz, BM Saqi, A Baergen, RN Caputo, TA
Citation: Ra. Soslow et al., Tumor suppressor gene, cell surface adhesion molecule, and multidrug resistance in Mullerian serous carcinomas: Clinical divergence without immunophenotypic differences, GYNECOL ONC, 79(3), 2000, pp. 430-437

Authors: Ferreira, JC Carter, SM Bernstein, PS Jabs, EW Glickstein, JS Marion, RW Baergen, RN Gross, SJ
Citation: Jc. Ferreira et al., Second-trimester molecular prenatal diagnosis of sporadic Apert syndrome following suspicious ultrasound findings, ULTRASOUN O, 14(6), 1999, pp. 426-430

Authors: Soslow, RA Remotti, H Baergen, RN Altorki, NK
Citation: Ra. Soslow et al., Suppression of apoptosis does not foster neoplastic growth in Barrett's esophagus, MOD PATHOL, 12(3), 1999, pp. 239-250

Authors: Soslow, RA Baergen, RN Warnke, RA
Citation: Ra. Soslow et al., B-lineage lymphoblastic lymphoma is a clinicopathologic entity distinct from other histologically similar aggressive lymphomas with blastic morphology, CANCER, 85(12), 1999, pp. 2648-2654
Risultati: 1-9 |